Product
Vehicle Control
4 clinical trials
6 indications
Indication
BlepharitisIndication
Diabetic RetinopathyIndication
Neurotrophic KeratopathyIndication
Muscle InjuryIndication
RecoveryIndication
Pain ReliefClinical trial
Randomized Controlled, Multicenter, Double-Masked, Parallel Phase III Trial to Evaluate the Efficacy and Safety of Lotilaner Ophthalmic Solution for the Treatment of Demodex Blepharitis in China With an Open-Label Pharmacokinetics Sub-StudyStatus: Active (not recruiting), Estimated PCD: 2023-09-15
Clinical trial
OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)Status: Completed, Estimated PCD: 2023-12-29
Clinical trial
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis SubjectsStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle InjuryStatus: Completed, Estimated PCD: 2024-03-21